Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prolia
Pharma
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Biosimilars to Amgen’s lucrative bone drugs Prolia and Xgeva triumphed at the FDA, though ongoing patent litigation makes the launch timing uncertain.
Fraiser Kansteiner
Mar 6, 2024 9:52am
Amgen's Prolia flagged by the FDA for risk of hypocalcemia
Jan 19, 2024 3:35pm
Amgen takes Novartis' Sandoz to court over bone med biosimilar
May 5, 2023 9:35am
Which drug price increases led to the most US spending?
Dec 7, 2022 9:20am
Bushu and Amgen expand Asian contract manufacturing pact
Nov 24, 2021 11:15am
The top 15 blockbuster patent expirations coming this decade
Jul 12, 2021 3:00am